Status:
COMPLETED
Novel Prognostic Markers in Renal Cancer
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
Brief Summary
The purpose of this project is to analyze tumour tissue from a group of subjects with renal cell carcinoma, who have been treated at the Royal Marsden Hospital.
Detailed Description
Renal cancers have different clinical outcomes. The principal research objective is to study tumour tissue from renal cancer patients and try and understand why some cancers progress more rapidly than...
Eligibility Criteria
Inclusion
- The presence of histologically proven renal cell cancer
- The availability of paraffin embedded tissue
- Informed consent needed for tissue taken after January 2006 (date of enforcement of human tissue act)
Exclusion
- Absence of histological tissue
- Absence of consent to study tissue after January 2006
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 17 2014
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT01002937
Start Date
December 1 2008
End Date
December 17 2014
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom, SM2 5PT